E
Bengaluru biotech developing affordable stem-cell therapies for retinal diseases; lead product EyeCyte-RPE targets dry age-related macular degeneration.
- Sector
- Healthtech
- Tags
- Biotech, Cell Therapy, Ophthalmology
- Area
- Whitefield
- Founded
- 2015
- Team size
- 11-50
- Total funding
- $19.9M
- Investors
- Biological E, Alkem Laboratories